SYNE1 and colorectal carcinoma: With regards to epigenetics, hypermethylation of SYNE1 has been identified as a key factor in colitis-associated cancer (CAC) carcinogenesis and is a potential biomarker to identify patients at higher risk of CRC (Papadia et al., 2014).